Bruno Sepodes
Lisbon, Portugal
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 90 publications
Analysis of a decade of post-authorisation studies for medicines approved by the EMA.
Journal: Nature reviews. Drug discovery
Published: June 10, 2026
From complexity to approval in the European Union: Regulatory pathways and data challenges in the evaluation of non-oncology orphan medicines.
Journal: Drug discovery today
Published: March 08, 2026
From complexity to approval in the European Union: regulatory pathways and data challenges in the evaluation of non-oncology orphan medicines.
Journal: Drug discovery today
Published: March 08, 2026
Balancing benefit and risk in early Alzheimer's disease: the European Medicines Agency (EMA) assessment of lecanemab and donanemab.
Journal: The Lancet regional health. Europe
Published: November 20, 2025
European Medicines Agency approvals of new medicines in September and October 2025.
Journal: The Lancet regional health. Europe
Published: November 03, 2025
Impact of adding immune checkpoint inhibitors to standard therapies in non-small cell lung cancer: A systematic review of efficacy outcomes.
Journal: Critical reviews in oncology/hematology
Published: October 25, 2025
European Medicines Agency seeks stakeholders' views on its reflection paper on patient experience data.
Journal: British journal of clinical pharmacology
Published: October 17, 2025
Trends in EU regulatory assessment of oncology medicines.
Journal: ESMO open
Published: October 02, 2025
Regulation of inflammatory pathways by cannabigerol in the collagen induced arthritis model in rats.
Regulation of inflammatory pathways by cannabigerol in the collagen induced arthritis model in rats.
Journal: Frontiers in pharmacology
Published: September 15, 2025
Novel approaches to the stratified management of knee osteoarthritis.
Journal: Nature reviews. Rheumatology
Published: September 05, 2025
Patient-Reported Outcomes Used for Regulatory Approval of Medicines Indicated for the Treatment of Dermatological Diseases Authorized in the European Union Between 1998 and 2024.
Journal: Therapeutic innovation & regulatory science
Published: July 28, 2025
Last Updated: 09/26/2026